Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS

NCT07449572 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

ARDS (Acute Respiratory Distress Syndrome)

Interventions

DRUG: HT31-1
OTHER: Saline (0.9%, sterile, for infusion)

Sponsor

HTIC, Inc